دورية أكاديمية

P-126 TROPION-PanTumor03, a phase 2, multicentre study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients with advanced/metastatic solid tumours: Substudies in gastric and colorectal cancer

التفاصيل البيبلوغرافية
العنوان: P-126 TROPION-PanTumor03, a phase 2, multicentre study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients with advanced/metastatic solid tumours: Substudies in gastric and colorectal cancer
المؤلفون: Oaknin, A., Meric-Bernstam, F., Lang, J., Ciombor, K., Ray-Coquard, I., Oza, A., Yonemori, K., Xu, R., Zhao, J., Gajavelli, S., Filant, J., Hovey, T., Janjigian, Y.
المصدر: In Annals of Oncology June 2023 34 Supplement 1:S59-S60
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.04.182